Handelsbanken Fonder
CGON icon

Handelsbanken Fonder’s CG Oncology CGON Stock Holding History

Handelsbanken Fonder’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.56M Buy
21,900
+1,200
+6% +$78.4K ﹤0.01% 930
2026
Q1 		$1.4M Buy
20,700
+1,600
+8% +$90.7K ﹤0.01% 892
2025
Q4 		$793K Sell
19,100
-3,900
-17% -$161K ﹤0.01% 1144
2025
Q3 		$926K Buy
23,000
+5,500
+31% +$160K ﹤0.01% 1036
2025
Q2 		$455K Buy
17,500
+4,200
+32% +$101K ﹤0.01% 1289
2025
Q1 		$326K Hold
13,300
– – ﹤0.01% 1379
2024
Q4 		$381K Buy
+13,300
New +$455K ﹤0.01% 1389

Other funds holding CGON

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
WB
WesBanco Bank Wheeling, West Virginia $4.02B AUM 32.62% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $2B AUM 42.86% 1-Year Est. Return

Handelsbanken Fonder's CGON Position: Q2 2026 in Review

Handelsbanken Fonder increased its CG Oncology (CGON) stake by 5.8% in Q2 2026, buying an estimated $78.4K and bringing the position to 21,900 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #930.

Handelsbanken Fonder first reported a position in CGON in Q4 2024 and has held it in 7 quarters since. 42 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Handelsbanken Fonder held 21,900 shares of CG Oncology worth $1.56M as of Q2 2026.
  • Handelsbanken Fonder bought 1,200 CG Oncology shares in Q2 2026, an estimated $78.4K.
  • CG Oncology made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #930 holding.
  • Handelsbanken Fonder first reported a position in CG Oncology in Q4 2024 and has held it in 7 quarters since.
  • 42 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.